Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Radical Resection Rates in Patients With Breast Cancer by Intraoperative Imaging Using Bevacizumab-IRDye800CW - the MARGIN-2 Study

NCT05939310 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05939310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05939310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Radical Resection Rates in Patients With Breast Cancer by Intraoperative Imaging Using Bevacizumab-IRDye800CW - the MARGIN-2 Study
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2024
Completion date
December 30, 2024
Enrollment
70 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer invasive